Weight Loss | Arena Soars After Weight-Loss Pill Wins Panel Backing
May 19, 2012 – 4:54 am
Arena Pharmaceuticals Inc. (ARNA) jumped themost ever after the company’s weight-loss pill gained thebacking of an advisory panel, putting two obesity drugs in linefor U.S. approval almost two years after regulators rejectedthem as too risky. Arena rose 74 percent to $6.36 at 4 p.m. New York time, thebiggest increase since the company’s shares began tradingpublicly in July 2000. Food and Drug
Tags: Weight Loss










